Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178711-13-000012
Filing Date
2013-03-12
Accepted
2013-03-12 16:41:00
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tspt-12312012x10k.htm 10-K 1935505
2 THIRD AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY directorequitycomppolicyex.htm EX-10.14 18066
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibit231.htm EX-23.1 5577
4 CERTIFICATION OF THE COMPANY'S CEO PURSUANT TO SECTION 302 tspt-12312012x10kex311.htm EX-31.1 13058
5 CERTIFICATION OF THE COMPANY'S CFO PURSUANT TO SECTION 302 tspt-12312012x10kex312.htm EX-31.2 13166
6 CERTIFICATION OF THE COMPANY'S CEO AND CFO PURSUANT TO SECTION 906 tspt-12312012x10kex321.htm EX-32.1 8982
13 GRAPHIC tspt-12312012x10k_chart.jpg GRAPHIC 247791
  Complete submission text file 0001178711-13-000012.txt   11122163

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tspt-20121231.xml EX-101.INS 1834593
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tspt-20121231.xsd EX-101.SCH 54015
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tspt-20121231_cal.xml EX-101.CAL 71782
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tspt-20121231_def.xml EX-101.DEF 300262
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tspt-20121231_lab.xml EX-101.LAB 711045
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tspt-20121231_pre.xml EX-101.PRE 429324
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51967 | Film No.: 13684678
SIC: 2834 Pharmaceutical Preparations